| Jose Carlos Hernandez, MD | |
|
7900 N Kings Hwy, Myrtle Beach, SC 29572-3055 | |
| (843) 449-3381 | |
| (843) 449-9721 |
| Full Name | Jose Carlos Hernandez |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 7900 N Kings Hwy, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578755773 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand Strand Regional Medical Center | Myrtle beach, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Strand Gi Associates Pa | 2163413717 | 14 |
News Archive
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of the Phase II portion of a Phase I/II clinical trial of TAK-700 in patients with advanced prostate cancer.
When it comes to health insurance, deciding what is an essential benefit — and what isn't — is a political and medical minefield, with far-reaching consequences.
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B and hepatitis C in China and India.
› Verified 9 days ago
| Entity Name | Strand Gi Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700864519 PECOS PAC ID: 2163413717 Enrollment ID: O20040521000433 |
News Archive
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of the Phase II portion of a Phase I/II clinical trial of TAK-700 in patients with advanced prostate cancer.
When it comes to health insurance, deciding what is an essential benefit — and what isn't — is a political and medical minefield, with far-reaching consequences.
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B and hepatitis C in China and India.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose Carlos Hernandez, MD 7900 N Kings Hwy, Myrtle Beach, SC 29572-3055 Ph: (843) 449-3381 | Jose Carlos Hernandez, MD 7900 N Kings Hwy, Myrtle Beach, SC 29572-3055 Ph: (843) 449-3381 |
News Archive
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of the Phase II portion of a Phase I/II clinical trial of TAK-700 in patients with advanced prostate cancer.
When it comes to health insurance, deciding what is an essential benefit — and what isn't — is a political and medical minefield, with far-reaching consequences.
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B and hepatitis C in China and India.
› Verified 9 days ago
Gary A Vukov, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 7900 N Kings Hwy, Myrtle Beach, SC 29572 Phone: 843-449-3381 Fax: 843-839-0275 | |
Gregory L Becker, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 906 Medical Cir, Myrtle Beach, SC 29572 Phone: 843-497-5929 Fax: 843-839-1037 | |
Andrew Peter Mangano, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 920 Doug White Dr Ste 250, Myrtle Beach, SC 29572 Phone: 843-236-1950 Fax: 843-236-1952 | |
Dr. Eunice Luz Guzman, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4220 Carolina Exchange Dr, Myrtle Beach, SC 29579 Phone: 843-663-8371 | |
Jacob Hurlan Brazee, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4301 Dick Pond Rd, Myrtle Beach, SC 29588 Phone: 843-652-8100 Fax: 843-652-8122 | |
Dr. Emily Zaruhi Touloukian, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8121 Rourk St, Myrtle Beach, SC 29572 Phone: 843-692-5000 | |
Dr. Jocelyn A Myers, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 945 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-497-5929 |